For almost two decades, Stanford electrical engineering professor Krishna Shenoy and neuroscientists in his Neural Prosthetics Translational Laboratory have been working on implantable brain sensors that allow them to record and decipher the electrical activity of neurons that control body movement.
The long-term goal: to build prosthetics that amputees and those with paralysis can control with their thoughts.
Currently, the process of analyzing neural activity is time-consuming and laborious. But in a paper in the journal Neuron, Shenoy and his team reveal that they have established a vastly simpler way to study the brain’s electrical activity. Their findings could one day open the door to a new age of super-compact, low-power, potentially wireless brain sensors that would bring thought-controlled prosthetics into much wider use.
In essence, the team has circumvented today’s painstaking process of tracking the activity of individual neurons in favor of decoding neural activity in the aggregate. Each time a neuron fires it sends an electrical signal — known as a “spike” — to the next neuron down the line. It’s the sort of intercellular communication that turns a notion in the mind into muscle contraction elsewhere in the body. “Each neuron has its own electrical fingerprint and no two are identical,” says Eric Trautmann, a postdoctoral researcher in Shenoy’s lab and first author of the paper.
Neuroscientists call that process “spike sorting,” and it must be done for every neuron in every experiment, an endeavor that eats up many thousands of hours of researcher time each year and is only going to get more time consuming as scientists build implants with greater numbers of electrodes. Indeed, researchers estimate that sensors will have 1,000 or more electrodes — up from 100 today — at which point, it would take a neuroscientist 100 hours or more to sort the spikes by hand for every experiment.
Image Credit: neurosciencenews.com
Thanks to Heinz V. Hoenen. Follow him on twitter: @HeinzVHoenen
News This Week
A South African laboratory study using Covid-19 samples from an immunosupressed individual over six months showed that the virus evolved to become more pathogenic, indicating that a new variant could cause worse illness than [...]
For the past several months, Omicron subvariants BA.4 and BA.5 have dominated COVID-19 cases in the U.S. But now, there’s a class of new COVID subvariants on the rise and one in particular is getting plenty of [...]
Nucleic acid therapies involving DNA or RNA have significant potential to treat genetic disorders, infectious diseases, and cancer; however, research suggests that less than 1% of injected nucleic acid doses reach target cells in [...]
The US Food and Drug Administration on Tuesday approved Hemgenix, a new drug to treat hemophilia. Manufacturer CSL Behring set the price at $3.5 million per treatment, making it the most expensive drug [...]
Some wounds just won’t heal. Infections, diseases like diabetes, and suppressed immune systems often stack up to slow healing. Chronic wounds can last months and lead to anxiety and depression. In the worst cases, [...]
Over the years, researchers have tried hard to comprehend topographic signals that promote cell mechanical sensitive responses. The extracellular matrix (ECM) provides a complex cellular microenvironment that controls cellular behavior. Nevertheless, only a few [...]
There is now an imminent threat of measles spreading in various regions globally, as COVID-19 led to a steady decline in vaccination coverage and weakened surveillance of the disease, the World Health Organization (WHO) [...]
In a recent study, it was shown that people with long Covid have had physical changes to their brains several months after experiencing the initial infection. The study included MRIs of patients who continued [...]
Western University in London, Ont., is building a unique research lab to study humanity's greatest viral threats — a secret weapon, if you will, one that it's expected would put Canada and the world in a better position if [...]
Cancer patients are testing a medicine made of antibodies that were designed from scratch on a computer in Israel and whose inventor has “programmed” them to “decide” whether cells surrounding tumors are bad or good. [...]
In an article published in the journal Scientific Reports, researchers presented the potentiostatic deposition used to electrodeposit nickel (Ni) and nickel-graphene (Ni-G) films on copper substrates. Myristic acid (MA) was employed to alter the plane of the [...]
Oregon State University scientists have invented a way to make magnetic nanoparticles that get hotter than any previous nanoparticle, improving their cancer fighting ability. Faculty from the OSU College of Pharmacy spearheaded a collaboration [...]
November 14, 2022 -- Researchers at the University of Texas MD Anderson Cancer Center have developed a nanotechnology platform that changes the immune system's perception of solid tumor cells, making them more receptive to immunotherapy. [...]
Nanotechnology platform enables immune conversion of cancer cells, sensitizing them to immunotherapy
A team of researchers at The University of Texas MD Anderson Cancer Center has developed a nanotechnology platform that can change the way the immune system sees solid tumor cells, making them more receptive [...]
Researchers learn to engineer growth of crystalline materials consisting of nanometer-size gold clusters
First insights into engineering crystal growth by atomically precise metal nanoclusters have been achieved in a study performed by researchers in Singapore, Saudi Arabia and Finland. The work was published in Nature Chemistry ("Supercrystal engineering of [...]